MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)
$0.6528 -0.0499 (-7.1012%)
Analysed MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) News Sources
Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
12-08-2026
yahoo.com
Milestone Pharmaceuticals Q2 Earnings Call Highlights
12-08-2026
marketbeat.com
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
21-08-2026
yahoo.com
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
21-08-2026
advfn.com
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
02-09-2026
yahoo.com
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
03-09-2026
yahoo.com
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
24-09-2026
yahoo.com
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
09-10-2026
yahoo.com
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
19-10-2026
yahoo.com
Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Falls As Analysts Reset Cardamyst Expectations
23-10-2026
yahoo.com
What is the current price of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The current price of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is $0.6528.
MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) absolute price change since previous trading day?
The absolute price change of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) since the previous trading day is $-0.0499.
MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) percentage price change since previous trading day?
The percentage price change of MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) since the previous trading day is -7.1012%.
What is the most recent average sentiment score for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The most recent average sentiment score for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)?
The most recent sentiment for MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ) is .
SEC-8K** Filing Available For MILESTONE PHARMACEUTICALS IN (MIST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.